• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于分析和解释 COVID-19 临床数据的因果学习框架。

A causal learning framework for the analysis and interpretation of COVID-19 clinical data.

机构信息

Scuola Normale Superiore, Pisa, Italy.

Institute of Clinical Physiology, C.N.R, Pisa, Italy.

出版信息

PLoS One. 2022 May 19;17(5):e0268327. doi: 10.1371/journal.pone.0268327. eCollection 2022.

DOI:10.1371/journal.pone.0268327
PMID:35588440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9119448/
Abstract

We present a workflow for clinical data analysis that relies on Bayesian Structure Learning (BSL), an unsupervised learning approach, robust to noise and biases, that allows to incorporate prior medical knowledge into the learning process and that provides explainable results in the form of a graph showing the causal connections among the analyzed features. The workflow consists in a multi-step approach that goes from identifying the main causes of patient's outcome through BSL, to the realization of a tool suitable for clinical practice, based on a Binary Decision Tree (BDT), to recognize patients at high-risk with information available already at hospital admission time. We evaluate our approach on a feature-rich dataset of Coronavirus disease (COVID-19), showing that the proposed framework provides a schematic overview of the multi-factorial processes that jointly contribute to the outcome. We compare our findings with current literature on COVID-19, showing that this approach allows to re-discover established cause-effect relationships about the disease. Further, our approach yields to a highly interpretable tool correctly predicting the outcome of 85% of subjects based exclusively on 3 features: age, a previous history of chronic obstructive pulmonary disease and the PaO2/FiO2 ratio at the time of arrival to the hospital. The inclusion of additional information from 4 routine blood tests (Creatinine, Glucose, pO2 and Sodium) increases predictive accuracy to 94.5%.

摘要

我们提出了一种临床数据分析工作流程,该工作流程依赖于贝叶斯结构学习(BSL),这是一种无监督学习方法,能够抵抗噪声和偏差,允许将先前的医学知识纳入学习过程,并以显示分析特征之间因果关系的图形形式提供可解释的结果。该工作流程由多个步骤组成,从通过 BSL 确定患者结果的主要原因开始,到基于二叉决策树(BDT)实现适合临床实践的工具,以识别在入院时已有信息的高风险患者。我们在富含特征的冠状病毒病(COVID-19)数据集上评估了我们的方法,表明所提出的框架提供了对共同导致结果的多因素过程的示意性概述。我们将我们的发现与 COVID-19 的当前文献进行了比较,表明这种方法允许重新发现有关该疾病的既定因果关系。此外,我们的方法产生了一个高度可解释的工具,可以仅基于 3 个特征正确预测 85%的受试者的结果:年龄、慢性阻塞性肺疾病病史和到达医院时的 PaO2/FiO2 比值。从 4 项常规血液检查(肌酐、葡萄糖、pO2 和钠)中包含更多信息可将预测准确性提高到 94.5%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/600b95829956/pone.0268327.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/057fc10a817c/pone.0268327.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/5e2efc387a81/pone.0268327.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/0c9d550db458/pone.0268327.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/aae8606b73c0/pone.0268327.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/600b95829956/pone.0268327.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/057fc10a817c/pone.0268327.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/5e2efc387a81/pone.0268327.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/0c9d550db458/pone.0268327.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/aae8606b73c0/pone.0268327.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df5/9119448/600b95829956/pone.0268327.g005.jpg

相似文献

1
A causal learning framework for the analysis and interpretation of COVID-19 clinical data.用于分析和解释 COVID-19 临床数据的因果学习框架。
PLoS One. 2022 May 19;17(5):e0268327. doi: 10.1371/journal.pone.0268327. eCollection 2022.
2
Smooth Bayesian network model for the prediction of future high-cost patients with COPD.用于预测 COPD 未来高费用患者的平滑贝叶斯网络模型。
Int J Med Inform. 2019 Jun;126:147-155. doi: 10.1016/j.ijmedinf.2019.03.017. Epub 2019 Apr 4.
3
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.随机临床试验评估 COVID-19 住院患者使用恢复期血浆的安全性和疗效(PERUCONPLASMA):一项随机对照试验研究方案的结构化总结。
Trials. 2021 May 17;22(1):342. doi: 10.1186/s13063-021-05189-6.
4
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.双盲、随机、对照临床试验评估同种异体间充质基质细胞治疗 COVID-19 所致急性呼吸窘迫综合征患者的疗效(COVID-AT):一项随机对照试验的研究方案的结构总结。
Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.
5
COVID-Net Biochem: an explainability-driven framework to building machine learning models for predicting survival and kidney injury of COVID-19 patients from clinical and biochemistry data.COVID-Net 生化:一个基于可解释性的框架,用于构建基于临床和生化数据预测 COVID-19 患者生存和肾脏损伤的机器学习模型。
Sci Rep. 2023 Oct 9;13(1):17001. doi: 10.1038/s41598-023-42203-0.
6
Machine learning algorithms for predicting COVID-19 mortality in Ethiopia.用于预测埃塞俄比亚 COVID-19 死亡率的机器学习算法。
BMC Public Health. 2024 Jun 28;24(1):1728. doi: 10.1186/s12889-024-19196-0.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Development and Validation of a Robust and Interpretable Early Triaging Support System for Patients Hospitalized With COVID-19: Predictive Algorithm Modeling and Interpretation Study.开发和验证用于 COVID-19 住院患者的强大且可解释的早期分诊支持系统:预测算法建模和解释研究。
J Med Internet Res. 2024 Jan 11;26:e52134. doi: 10.2196/52134.
9
Explainable machine learning models based on multimodal time-series data for the early detection of Parkinson's disease.基于多模态时间序列数据的可解释机器学习模型用于帕金森病的早期检测。
Comput Methods Programs Biomed. 2023 Jun;234:107495. doi: 10.1016/j.cmpb.2023.107495. Epub 2023 Mar 23.
10
An algorithm for direct causal learning of influences on patient outcomes.一种用于直接因果学习对患者预后影响的算法。
Artif Intell Med. 2017 Jan;75:1-15. doi: 10.1016/j.artmed.2016.10.003. Epub 2016 Nov 5.

本文引用的文献

1
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis.COVID-19 的 50 多种长期影响:系统评价和荟萃分析。
Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8.
2
Classification of COVID-19 individuals using adaptive neuro-fuzzy inference system.使用自适应神经模糊推理系统对新冠肺炎患者进行分类
Multimed Syst. 2022;28(4):1223-1237. doi: 10.1007/s00530-021-00774-w. Epub 2021 Mar 28.
3
Predictors of morbidity and mortality in COVID-19.COVID-19 患者的发病率和死亡率预测因素。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1684-1707. doi: 10.26355/eurrev_202102_24880.
4
Association of smoking history with severe and critical outcomes in COVID-19 patients: A systemic review and meta-analysis.吸烟史与COVID-19患者严重及危重结局的关联:一项系统评价与荟萃分析。
Eur J Integr Med. 2021 Apr;43:101313. doi: 10.1016/j.eujim.2021.101313. Epub 2021 Feb 18.
5
The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study.合并症对 COVID-19 严重程度的预后价值:一项系统评价和荟萃分析研究。
PLoS One. 2021 Feb 16;16(2):e0246190. doi: 10.1371/journal.pone.0246190. eCollection 2021.
6
Which COVID policies are most effective? A Bayesian analysis of COVID-19 by jurisdiction.哪些 COVID 政策最有效?基于管辖范围对 COVID-19 的贝叶斯分析。
PLoS One. 2020 Dec 29;15(12):e0244177. doi: 10.1371/journal.pone.0244177. eCollection 2020.
7
Prevalence of dementia and its impact on mortality in patients with coronavirus disease 2019: A systematic review and meta-analysis.COVID-19 患者痴呆的患病率及其对死亡率的影响:系统评价和荟萃分析。
Geriatr Gerontol Int. 2021 Feb;21(2):172-177. doi: 10.1111/ggi.14107. Epub 2020 Dec 19.
8
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.全球 COVID-19 荟萃分析显示,男性性别是死亡和 ICU 入院的风险因素。
Nat Commun. 2020 Dec 9;11(1):6317. doi: 10.1038/s41467-020-19741-6.
9
Artificial Intelligence in the Fight Against COVID-19: Scoping Review.人工智能在抗击 COVID-19 中的应用:范围综述。
J Med Internet Res. 2020 Dec 15;22(12):e20756. doi: 10.2196/20756.
10
Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.COVID-19 住院患者的肝脏疾病和结局 - 系统评价和荟萃分析。
Ann Hepatol. 2021 Mar-Apr;21:100273. doi: 10.1016/j.aohep.2020.10.001. Epub 2020 Oct 16.